Table 2.
Procedural characteristics with composite outcome (N = 795)
| Procedure variables | Men (n = 448) | Women (n = 347) |
|---|---|---|
| TAVR type: balloon expandable valve | 163 (36.5) | 140 (40.2) |
| TAVR size, mm | 27.36 ± 2.99 | 25.10 ± 2.42 |
| Access | – | – |
| Transfemoral | 425 (95.1) | 337 (96.8) |
| Transapical | 17 (3.8) | 10 (2.9) |
| Trans-subclavian | 2 (0.4) | 1 (0.3) |
| Transaortic | 3 (0.7) | 0 (0.0) |
| Acute procedural success | 444 (99.3) | 342 (98.3) |
| PCI, before and after | 79 (17.7) | 41 (11.8) |
| Bleeding | – | – |
| No | 338 (75.6) | 248 (71.3) |
| Minor | 9 (2.0) | 174 (50.0) |
| Major | 20 (4.5) | 13 (3.7) |
| Life threatening | 80 (17.9) | 12 (3.4) |
| Mean gradient after TAVR, mm Hg | 9.61 ± 4.88 | 10.96 ± 5.98 |
| Mean gradient after TAVR | – | – |
| <10 mm Hg | 248 (57.0) | 154 (45.7) |
| 10-20 mm Hg | 174 (40.0) | 164 (48.7) |
| >20 mm Hg | 13 (3.0) | 19 (5.6) |
| Paravalvular leak | – | – |
| No | 310 (69.4) | 261 (75.0) |
| Mild | 112 (25.1) | 73 (21.0) |
| Moderate to severe | 25 (5.6) | 14 (4.0) |
| Balloon dilation, before or after | 83 (18.6) | 59 (17.05) |
| PPM | 60 (13.4) | 35 (10.1) |
| Post-TAVR CVA | 7 (1.6) | 4 (1.1) |
| Post-TAVR MI (clinically relevant) | 2 (0.4) | 3 (0.9) |
| Post-TAVR death | 11 (2.5) | 9 (2.6) |
| General Anesthesia | 128 (28.6) | 115 (33.0) |
| Complication | – | – |
| None | 418 (93.5) | 322 (92.5) |
| Coronary obstruction | 4 (0.9) | 5 (1.4) |
| Rupture | 0 (0.0) | 2 (0.6) |
| Embolization | 4 (0.9) | 4 (1.1) |
| Other | 21 (4.7) | 15 (4.3) |
| Emergency surgery | 6 (1.3) | 5 (1.4) |
Values are mean ± SD or n (%).
CVA, cerebrovascular accident; MI, myocardial infarction; PCI, percutaneous coronary intervention; PPM, permanent pacemaker; TAVR, transcatheter aortic valve replacement.